Abstract：Objective: To monitor the sleep monitoring characteristics and clinical manifestations of adult patients with Obstructive sleep apnea hypopnea syndrome (OSAHS), and to make a comparative analysis of the sleep monitoring characteristics and clinical manifestations of adult patients of different age groups, so as to provide a basis for the understanding, diagnosis and treatment of clinical OSAHS. Methods: 168 elderly patients with OSAHS were studied from January 2016 to December 2018. They were divided into two groups according to age, namely, 80 cases in the elderly group (elderly population) and 88 cases in the middle-aged and young group (middle-aged and young population). Polysomnography monitoring results, clinical manifestations, personal history and the occurrence of complicated diseases of the two groups were compared and evaluated. Results: The typical clinical manifestations of snoring, apnea, waking up at night and lethargy in young and middle-aged patients were higher than those in the elderly group. Young and middle-aged patients apnea hypopnea index (AHI) higher than the elderly group, elderly group patients CT90 %, micro awakening, oxygen reduction index, Ⅰ period as a percentage of total sleep time, Ⅲ period as a percentage of total sleep time and REM sleep time as a percentage of total sleep time, total sleep apnea time than young and middle-aged group, there were significant differences, P < 0.05;The proportion of patients with coronary heart disease in the elderly group was higher than that in the young and middle-aged group, with statistical difference (P < 0.05). Conclusion: The clinical manifestations of OSAHS patients in the young and middle-aged group were typical, AHI is high and the degree of disease is serious; the clinical manifestations of OSAHS patients in the old group are not typical, sleep quality is poor, the proportion of chronic diseases such as coronary heart disease is high and the risk is high.
[1] 卢俏丽,薛蓉,董丽霞,等.脑梗死伴阻塞性睡眠呼吸暂停低通气综合征患者睡眠结构及认知功能分析[J].中华神经科杂志,2016,45(3):298~299. [2] Lu D, Li N, Yao X, et al. Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome[J]. Bosnian Journal of Basic Medical Sciences, 2017, 17(1):47~53. [3] Su Y, Xu W, Wang X, et al. Prevalence of obstructive sleep apnea-hypopnea syndrome in adults aged over 60 years in dongying city[J]. Journal of Clinical Otorhinolaryngology Head & Neck Surgery, 2016, 30(4):299~305. [4] 李文球.不同年龄组小儿阻塞性睡眠呼吸暂停综合征的临床特征[J].医学新知,2017,27(5):537. [5] Wang Y, Yang Q, Feng J, et al. The prevalence and clinical features of hypertension in patients with obstructive sleep apnea hypopnea syndrome and related nursing strategies[J]. Journal of Nursing Research, 2016, 24(1):41~47. [6] Garciacampos E, Labra A, Galiciapolo L, et al. Decrease of respiratory events in patients with obstructive sleep apnea-hypopnea syndrome using a mandibular advancement device assessed with split night polysomnography.[J]. Sleep Science, 2016, 9(3):221~224. [7] Wu J, Gu M, Chen S, et al. Factors related to pediatric obstructive sleep apnea-hypopnea syndrome in children with attention deficit hyperactivity disorder in different age groups[J]. Medicine, 2017, 96(42):e8281. [8] Ma L, Zhang J, Liu Y. Roles and mechanisms of obstructive sleep apnea-hypopnea syndrome and chronic intermittent hypoxia in atherosclerosis: evidence and prospective[J]. Oxidative Medicine & Cellular Longevity, 2016,16(5):1~10. [9] Hernandez V A, Sayas C J, Benavides M P, et al. Obstructive sleep apnea-hypopnea syndrome in patients with severe chronic respiratory insufficiency[J]. Medicina Clinica, 2017, 148(10):449~452. [10] Jiang Y Q, Xue J S, Xu J, et al. Efficacy of continuous positive airway pressure treatment in treating obstructive sleep apnea hypopnea syndrome associated with carotid arteriosclerosis[J]. Experimental & Therapeutic Medicine, 2017, 14(6):6176~6182.
2020, Vol. 26 
冀公网安备13080202000677号